The Lancet: Better and safer treatment for multidrug-resistant tuberculosis
"From a patient's point of view, treatment of multidrug-resistant tuberculosis has advanced very little in the past 40 years. A long and difficult course of treatment, even when successful, usually means episodes of serious or life-threatening side-effects or disease complications. Patients who push through are not guaranteed a cure...."
Read the rest of Dr. Paul Farmer's Comment here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)3214…